Online Inquiry
Cat.#: ACPP-1368
| Despition | KCNJ2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1171 | Recombinant Human KCNK9 Protein (Fc Tag) (AC1171) | 50 µg | inquiry |
| ACPP-1056 | Recombinant Human CX3CR1 Protein (Fc Tag) (AC1056) | 50 µg | inquiry |
| ACPP-1651 | Human AIDA Protein (AC1651) | 2 µg | inquiry |
| ACPP-1380 | Human LECT2 Protein (AC1380) | 2 µg | inquiry |
| ACPP-1371 | Ki67 Blocking Peptide (AC1371) | 250 µg | inquiry |
| ACPP-1112 | Recombinant Human Eph Receptor A2 Protein (6×His Tag) (AC1112) | 50 µg | inquiry |
| ACPP-1207 | Dopamine Receptor D1 Blocking Peptide (AC1207) | 250 µg | inquiry |
| ACPP-1273 | BTB/POZ domain-containing protein 7 Blocking Peptide (AC1273) | 250 µg | inquiry |
| ACPP-1707 | Human RAB5B Protein (AC1707) | 5 µg | inquiry |
| ACPP-1743 | Human SCG5 Protein (AC1743) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.